Literature DB >> 2810959

Human breast carcinoma (ZR-75-1) serially transplanted into nude mice--with reference to estradiol dependency and sensitivity to tamoxifen.

T Kubota1, S Oka, T Utsumi, S Inoue, M Kuzuoka, A Suto, Y Arisawa, K Ishibiki, O Abe.   

Abstract

Tumor cells of the ZR-75-1 line (1 X 10(7) in 0.5 ml) were inoculated into the right thigh muscles of BALB/c female nude mice which were, at the same time given 1.0 mg of estradiol subcutaneously. After the transferable strain had been established, the tumors were then transplanted into female and male nude mice either with or without estradiol treatment. Although no exponential tumor growth was observed in the untreated male and female nude mice, no complete rejection was found during the experiments. The estrogen receptor of this strain was positive and the growth of ZR-75-1 was dependent on exogenous estradiol. ZR-75-1 in the nude mouse was insensitive to tamoxifen treatment, given as 5 mg/kg intramuscularly twice a week, suggesting that dependency on estradiol is not necessarily correlated with endocrine sensitivity to tamoxifen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810959     DOI: 10.1007/bf02471626

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  In vitro model systems for the study of hormone-dependent human breast cancer.

Authors:  M E Lippman; C K Osborne; R Knazek; N Young
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

2.  Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice.

Authors:  S Hirohashi; Y Shimosato; T Kameya; K Nagai; R Tsunematsu
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice.

Authors:  T Kubota; M Nakada; K Tsuyuki; T Inada; F Asanuma; K Ishibiki; O Abe
Journal:  Jpn J Cancer Res       Date:  1986-05

4.  [Effect of hydroxy tamoxifens against human breast carcinomas transplanted into nude mice].

Authors:  T Fukutomi; T Ikeda; T Nishiumi; S Kikuyama; Y Isobe; A Nakamura; M Shimada; T Inada; S Ishii; J Koh
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1986-02-20

Review 5.  Hormones in breast cancer: update 1978.

Authors:  W L McGuire; K B Horwitz; D T Zava; R E Garola; G C Chamness
Journal:  Metabolism       Date:  1978-04       Impact factor: 8.694

6.  Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice.

Authors:  T Fukutomi; T Kubota; T Ikeda; Y Isobe; S Kikuyama; A Shimada; A Nakamura; T Nishiumi; K Enomoto; K Ishibiki
Journal:  Jpn J Cancer Res       Date:  1986-01

7.  Human breast carcinoma (MCF-7) serially transplanted into nude mice.

Authors:  T Kubota; K Kubouchi; J Koh; K Enomoto; K Ishibiki; O Abe
Journal:  Jpn J Surg       Date:  1983-07

8.  Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.

Authors:  H Nawata; D Bronzert; M E Lippman
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

9.  Endocrine sensitivity of the receptor-positive T61 human breast carcinoma serially grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; H Skovgaard Poulsen; S A Engelholm; A Nielsen; L Vindeløv
Journal:  Int J Cancer       Date:  1985-01-15       Impact factor: 7.396

10.  [Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice].

Authors:  J Koh
Journal:  Nihon Geka Gakkai Zasshi       Date:  1988-01
  10 in total
  2 in total

1.  Models of breast cancer: is merging human and animal models the future?

Authors:  Jong B Kim; Michael J O'Hare; Robert Stein
Journal:  Breast Cancer Res       Date:  2003-08-19       Impact factor: 6.466

2.  Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen.

Authors:  K Josui; T Kubota; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1992-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.